Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 93
Introduction: Why study environmental carcinogenesis?
Margaret L. Kripke
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Environmental carcinogenesis: Progress, challenges, and opportunities
John R. Bucher
National Institutes of Health, Research Triangle Park, NC, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Endocrine disruptors and reproductive cancers
Joan V Ruderman
Princeton University, Princeton, NJ, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Contribution of environmental exposures to childhood cancers
Philip J Landrigan
Icahn School of Medicine at Mt. Sinai, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 10:15 AM-12:15 PM
Theranostics with Alpha and Auger electron-emitting targeted radionuclide therapy agents
Michael R. Zalutsky
Duke University, Durham, NC, United States
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
177Lu-labeled small molecule theranostics for metastatic melanoma and prostate cancer
Carolyn J. Anderson
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
Recent advances in theranostics targeting PSMA and CXCR4
Margret Schottelius
Technical University of Munich, Munich, Germany
from AACR Annual Meeting 2017 on April 4, 2017 10:30 AM-12:15 PM
Phase I study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
Jayesh Desai
Royal Melbourne Hospital, Melbourne, Australia
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Discussant
Udai Banerji
Inst. of Cancer Research, Sutton, United Kingdom
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic MET mutations. EORTC phase II trial 90101 "CREATE"
Patrick Schoffski
University Hospitals Leuven - Department of General Medical Oncology, Leuven, Belgium
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Discussant
Ravi Salgia
City of Hope, Duarte, CA, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Entrectinib, an oral pan-Trk, ROS1, and ALK inhibitor in TKI-naïve patients with advanced solid tumors harboring gene rearrangements: Updated phase I results
Alexander Drilon
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Clinical safety and activity from a phase I study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions
David S Hong
MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Discussant
Leena Gandhi
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:00 PM
Genome-scale analysis of DNA methylation in cancer: Discoveries, challenges, and opportunities
Hui Shen
Van Andel Research Inst., Grand Rapids, MI, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Prioritizing non-coding variants in cancer genomes using epigenetic profiles
Peter J. Park
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Modeling cancer gene regulation with public ChIP-seq profiles
X Shirley Liu
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 8:00 AM-10:00 AM
Transitional, technical, and biological approaches and advances to address unmet clinical needs
Lawrence B. Schook
University of Illinois at Urbana-Champaign, Urbana, IL, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Unmet clinical needs in oncology: The value of large animal models
George J. Weiner
University of Iowa Holden Comp. Cancer Center, Iowa City, IA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
The new pig on the block: Genome editing in cancer models
Angelika Schnieke
Technical University of Munich, Freising, Germany
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Organoid models and systems biology: From mouse to human
Michael M. Shen
Columbia University College of Physicians & Surgeons, New York, NY, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Acute lymphoblastic leukemia
Charles G. Mullighan
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Credentialing genomic medicine in pediatric oncology: Neuroblastoma as a model
Yael P. Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Pediatric and adult high grade gliomas: A tale of a histone tail
Nada Jabado
McGill University Department of Pediatrics, Montreal, QC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Phase I trial combining the PARP inhibitor olaparib (Ola) and AKT inhibitor AZD5363 (AZD) in germline (g)BRCA and non-BRCA mutant (m) advanced cancer patients (pts) incorporating noninvasive monitoring of cancer mutations
Vasiliki Michalarea
Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom
from AACR Annual Meeting 2016 on April 17, 2016 4:15 PM-6:15 PM
<< first | < prev page: of 4 records per page: next > | last >>
pages: 1 2 3 4 presentations: 1 to 25 of 93